- organizations:Bausch + Lomb
Products
B+L issues voluntary recall of certain IOLs in enVista platform
Recall follows an increase in reports of toxic anterior segment syndrome connected to implants of the enVista Aspire, Envy, and other monofocal IOLs.
Pipeline
Phase 4 data presents early patient-reported outcomes of MIEBO
Study finds symptom relief achieved as early as 5 to 60 minutes on day 1 of dosing—with significant reduction in overall severity after 14 days.
Products
Bausch + Lomb launches ortho-k lens fitting system
The Arise cloud-based platform syncs directly with diagnostic tools to create a customized lens design for myopia treatment in mere seconds—without the need for a fitting set.
Events
Eyecare companies offering support to LA wildfire victims
Industry leaders such as CooperVision, Alcon, Bausch + Lomb, and EssilorLuxottica are providing supplies and services to optometrists and residents in need.
Business
Bausch + Lomb may be acquiring InflammX Therapeutics
Option agreement indicates B+L intends to purchase the biotech company and its orally-administered therapeutic under clinical investigation for retinal diseases.
Business
Bausch + Lomb adds to glaucoma and GA pipeline with two deals
Latest developments involve the acquisition of WhiteCap Biosciences and its GA candidate, as well as a partnership with RNAi-focused City Therapeutics.
Events
Bausch + Lomb launches second annual glaucoma awareness campaign
As part of a partnership with the Glaucoma Research Foundation, this month-long initiative honors January as Glaucoma Awareness Month.
Business
Bausch + Lomb purchases Elios Vision
Acquisition includes the ELIOS procedure, an excimer laser-based and implant-free MIGS technology performed during cataract surgery for glaucoma treatment.
Products
Bausch + Lomb demos new Opal online ordering platform
E-commerce platform lets patients directly order from a customized catalog of products while minimizing and simplifying clinical practices’ administrative workload.
Business
Bausch + Lomb names leading ophthalmologist as strategic medical advisor
Industry veteran Cathleen McCabe, MD, will consult on the company’s expanding product portfolio and serve as liaison to the global ECP community.
Products
FDA approves Bausch + Lomb's en Vista Envy IOL
Offering a continuous range of vision with excellent dysphotopsia tolerance, the lens will be initially available on a limited basis.
Products
Bausch + Lomb launches new digital ordering marketplace
The Opal e-commerce platform enables patients to directly order contact lens products from a customized catalog, freeing up clinical practice staff time and resources.
Products
FDA grants tentative approval for Lupin's Lumify generic eye drops
Brimonidine tartrate ophthalmic solution, 0.025% is indicated to treat ocular redness due to minor irritations in the eye.
Research
Pivotal study supports B+L's TENEO laser for myopic LASIK surgery
Pivotal 9-month study on the FDA-approved excimer laser platform reports 97.8% and 100% of eyes achieving UCDVA and CDVA of 20/25 or better.
Research
AREDS supplements may slow late-stage dry AMD progression
NEI-supported analysis identifies significant benefits based on new data from the AREDS and AREDS2 studies.
Business
Bausch + Lomb acquires Trukera Medical
Purchase of the former TearLab Corporation includes the ScoutPro Osmolarity System, a point-of-care portable device for osmolarity testing.
Research
Bausch + Lomb reports national dry eye data, launches awareness tool
State of the Dry Eye survey finds 70% of patients lack knowledge and education of the disease.
Products
Zenni Optical now offers contact lens ordering of top brands
New prescription-based orders feature CooperVision and Bausch + Lomb lenses.
Products
Bausch + Lomb to launch INFUSE for Astigmatism SiHy lenses in the US
Latest one-day silicone hydrogel lens addition maintains 96% of moisture for 16 hours.
Products